(1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl (3aR,4S,7R,7aR)-octahydro-3aH-4,7-methanoindene-3a-carboxylate
CAS No: 109525-51-1
                
    
      Order
    
    2030-63-9
    
      N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine (Clofazimine)
    
  
  
  
  
  
            
                
                Inden
                            
                            
                            
                            
                                Order
                                760990-65-6
                                
                                    [1,1'-Biphenyl]-4-ol,4'-[1,4-dihydro-6-[(4-pyridinylamino)methyl]Indeno[1,2-c]pyrazol-3-yl]-
                                
                            
                            
                            
                                Order
                                88846-84-8
                                
                                    1H-Indeno[1,2-b]pyridine-3-carboxylic acid,4,5-dihydro-2-methyl-5-oxo-4-phenyl-, pentyl ester
                                
                            
                            
                                Order
                                760990-61-2
                                
                                    [1,1'-Biphenyl]-4-ol,4'-[1,4-dihydro-7-[[(2-hydroxyethyl)amino]methyl]Indeno[1,2-c]pyrazol-3-yl]-
                                
                            
                            
                            
                            
                
                 109525-51-1
                                dioxo,hexahydro,isoindol,methyl,octahydro,methanoindene,carboxylate,inden,indene,109525-51-1
            2025-10-28  Discover (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl (3aR,4S,7R,7aR)-octahydro-3aH-4,7-methanoindene-3a-carboxylate (CAS No: 109525-51-1) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.